Published online Jul 27, 2021. doi: 10.4331/wjbc.v12.i4.52
Peer-review started: February 21, 2021
First decision: April 20, 2021
Revised: May 17, 2021
Accepted: July 7, 2021
Article in press: July 7, 2021
Published online: July 27, 2021
Processing time: 151 Days and 20.2 Hours
This article examines the hype generated around the term “stem cell”, and the capitalization of the stem cell craze by the cosmetic industry. It started by introducing product lines containing active ingredients derived from plant stem cells. Then, evolved to using own cells for skin regeneration and hair loss treatment, and allogenic cells for the manufacturing of stem cell-derived products. This article also discusses the missing links for safe and reliable stem cell applications in cosmetics, and why local regulatory bodies, members of the industry and consumers must all work together to stop the illegitimate use of the “stem cell” good name in unsafe or fraudulent commercial practices.
Core Tip: The capitalization of the stem cell craze by the cosmetic industry. Products and procedures utilizing plant stem cells-extracts, a person’s own cells or allogenic laboratory grown stem-like cells, are all being offered as direct-to-consumer options for tissue regeneration. What are the missing links for safe and reliable stem cell applications in cosmetics, and why is it important to address these issues?
